Podcast
Questions and Answers
What is a primary focus of the AAN guidelines regarding the treatment of Parkinson's disease?
What is a primary focus of the AAN guidelines regarding the treatment of Parkinson's disease?
Which factor is not considered when choosing medications for patients with early Parkinson's disease?
Which factor is not considered when choosing medications for patients with early Parkinson's disease?
Which aspect is generally emphasized in managing patients with advanced Parkinson's disease according to the guidelines?
Which aspect is generally emphasized in managing patients with advanced Parkinson's disease according to the guidelines?
What does CPS emphasize when considering treatment for Parkinson’s disease?
What does CPS emphasize when considering treatment for Parkinson’s disease?
Signup and view all the answers
What does 'clinical equipoise' refer to in the context of Parkinson's disease treatment?
What does 'clinical equipoise' refer to in the context of Parkinson's disease treatment?
Signup and view all the answers
What is a common characteristic of Bradykinesia in patients?
What is a common characteristic of Bradykinesia in patients?
Signup and view all the answers
What is emphasized in the rehabilitation guidelines for patients with Parkinson's disease?
What is emphasized in the rehabilitation guidelines for patients with Parkinson's disease?
Signup and view all the answers
How did the patient MF describe the onset of his symptoms?
How did the patient MF describe the onset of his symptoms?
Signup and view all the answers
What major social activity did the patient MF stop due to his condition?
What major social activity did the patient MF stop due to his condition?
Signup and view all the answers
What does the term 'clinical equipoise' refer to in the context of Parkinson's disease treatment?
What does the term 'clinical equipoise' refer to in the context of Parkinson's disease treatment?
Signup and view all the answers
What do the outcomes of the Unified Parkinson Disease Rating Scale (UPDRS) primarily assess?
What do the outcomes of the Unified Parkinson Disease Rating Scale (UPDRS) primarily assess?
Signup and view all the answers
Which part of the UPDRS involves clinician assessment?
Which part of the UPDRS involves clinician assessment?
Signup and view all the answers
What is the focus of the QoL Measures in the context of Parkinson’s disease?
What is the focus of the QoL Measures in the context of Parkinson’s disease?
Signup and view all the answers
Which of the following is NOT included in the UPDRS motor exam?
Which of the following is NOT included in the UPDRS motor exam?
Signup and view all the answers
In the context of Parkinson’s disease, caregiver burden is primarily associated with which aspect?
In the context of Parkinson’s disease, caregiver burden is primarily associated with which aspect?
Signup and view all the answers
What is an example of a non-motor aspect evaluated from the patient's perspective in the UPDRS?
What is an example of a non-motor aspect evaluated from the patient's perspective in the UPDRS?
Signup and view all the answers
What is the primary aim of measuring time to clinical events in Parkinson’s disease management?
What is the primary aim of measuring time to clinical events in Parkinson’s disease management?
Signup and view all the answers
Which of these domains is NOT measured in the Parkinson's Impact Scale?
Which of these domains is NOT measured in the Parkinson's Impact Scale?
Signup and view all the answers
What is the primary indication for using dopamine agonists in the treatment of Parkinson's disease?
What is the primary indication for using dopamine agonists in the treatment of Parkinson's disease?
Signup and view all the answers
What is the mechanism of action of dopamine agonists?
What is the mechanism of action of dopamine agonists?
Signup and view all the answers
Which of the following dopamine agonists is classified as a newer agent?
Which of the following dopamine agonists is classified as a newer agent?
Signup and view all the answers
Which side effect profile is generally associated with older dopamine agonists compared to newer agents?
Which side effect profile is generally associated with older dopamine agonists compared to newer agents?
Signup and view all the answers
What is the recommended approach for titrating the dose of dopamine agonists?
What is the recommended approach for titrating the dose of dopamine agonists?
Signup and view all the answers
What would be the maximum dose of Pramipexole for a patient taking it three times daily?
What would be the maximum dose of Pramipexole for a patient taking it three times daily?
Signup and view all the answers
Which of the following is an important interaction to consider when prescribing dopamine agonists?
Which of the following is an important interaction to consider when prescribing dopamine agonists?
Signup and view all the answers
Which receptor type does Ropinirole primarily target?
Which receptor type does Ropinirole primarily target?
Signup and view all the answers
What is the significance of titrating down the dose of levodopa when a dopamine agonist is introduced?
What is the significance of titrating down the dose of levodopa when a dopamine agonist is introduced?
Signup and view all the answers
What kind of drug is Rasagiline classified as in the treatment of Parkinson's disease?
What kind of drug is Rasagiline classified as in the treatment of Parkinson's disease?
Signup and view all the answers
Which medication is specifically indicated for urinary retention management in patients?
Which medication is specifically indicated for urinary retention management in patients?
Signup and view all the answers
What is one of the primary benefits of surgical intervention with deep brain stimulation?
What is one of the primary benefits of surgical intervention with deep brain stimulation?
Signup and view all the answers
Which treatment option is recommended for managing hypersalivation?
Which treatment option is recommended for managing hypersalivation?
Signup and view all the answers
What is a common strategy for managing constipation in patients?
What is a common strategy for managing constipation in patients?
Signup and view all the answers
What complication is particularly associated with deep brain stimulation surgery?
What complication is particularly associated with deep brain stimulation surgery?
Signup and view all the answers
Which condition should be monitored to avoid complications when treating with medications?
Which condition should be monitored to avoid complications when treating with medications?
Signup and view all the answers
Which medication is commonly used for treating erectile dysfunction?
Which medication is commonly used for treating erectile dysfunction?
Signup and view all the answers
What type of injection may be used to treat hypersalivation?
What type of injection may be used to treat hypersalivation?
Signup and view all the answers
What is a common motor complication observed in patients on levodopa treatment after approximately five years?
What is a common motor complication observed in patients on levodopa treatment after approximately five years?
Signup and view all the answers
What therapeutic approach can be taken to address the wearing off phenomenon in levodopa treatment?
What therapeutic approach can be taken to address the wearing off phenomenon in levodopa treatment?
Signup and view all the answers
Which medication formulation allows for continuous infusion as a management option for levodopa?
Which medication formulation allows for continuous infusion as a management option for levodopa?
Signup and view all the answers
Which complication is characterized by an acute lack of dopamine leading to sustained muscle contractions?
Which complication is characterized by an acute lack of dopamine leading to sustained muscle contractions?
Signup and view all the answers
What is a potential management strategy for early or delayed dyskinesias associated with levodopa treatment?
What is a potential management strategy for early or delayed dyskinesias associated with levodopa treatment?
Signup and view all the answers
What type of infusion is delivered by the Vyalev solution for combating levodopa is a narrow therapeutic index drug?
What type of infusion is delivered by the Vyalev solution for combating levodopa is a narrow therapeutic index drug?
Signup and view all the answers
Which method is indicated for managing the on-off phenomenon in levodopa therapy?
Which method is indicated for managing the on-off phenomenon in levodopa therapy?
Signup and view all the answers
Which formulation of levodopa is delivered using a PEG-J tube?
Which formulation of levodopa is delivered using a PEG-J tube?
Signup and view all the answers
What psychiatric complication may occur in patients receiving long-term treatment for Parkinson's disease?
What psychiatric complication may occur in patients receiving long-term treatment for Parkinson's disease?
Signup and view all the answers
What strategy can be used for managing the wearing off phenomenon linked to levodopa therapy?
What strategy can be used for managing the wearing off phenomenon linked to levodopa therapy?
Signup and view all the answers
Study Notes
Parkinson's Disease
- A chronic, progressive neurological disorder characterized by tremor, bradykinesia, rigidity, and postural instability
- Current hypothesis links Parkinson's to genetic factors, toxin exposure, exogenous and endogenous factors like well water, farming, free radicals, infection and iron and emerging research into the gut microbiome and inflammation.
- 1817 - Essay on the Shaking Palsy
- 1884 - apomorphine
- 1961 - L-Dopa
- 1969 - dopa decarboxylase inhibitors
- 1973 - CR formulation
- 1977 - MPTP
- 1982 - pergolide
- 1994 - COMT inhibitors
- 2002 - DBS.
- In Parkinson's disease, degeneration of presynaptic nigrostriatal neurons inhibits thalamocortical circuit signaling to the motor cortex.
- Different dopamine tracts throughout the brain affect movement, arousal, motivation, reward, emotion, cognition, memory, and regulate prolactin release.
- D1 and D5 receptors result in depolarization, while D2, D3, and D4 receptors result in hyperpolarization of postsynaptic neurons.
Pathophysiology
- Dopaminergic pathways in the basal ganglia-thalamocortical circuit activate D1 and D2 receptors, leading to depolarization and hyperpolarization respectively, of postsynaptic neurons.
- Degeneration of presynaptic nigrostriatal neurons in Parkinson's disease inhibits thalamocortical circuit signaling to the motor cortex.
- Reduction in neurotransmitter activity occurs, impacting the signalling pathways in the globus pallidus externa (GPe), globus pallidus interna (GPi), substantia nigra pars compacta (SNc), substantia nigra pars reticulata (SNr), and the subthalamic nucleus (STN).
Risk Factors
- Increased risk factors: Age, rural residence, farming, pesticide exposure, and frequent dairy consumption
- Protective factors: Cigarette smoking, coffee, tea, caffeine (3-5 mg/kg dose), and dietary factors like Vitamin D, sex hormones, homocysteine, and hypertension. Medications like NSAIDs and statins may be protective.
- Environmental factors: Exposure to volatile organic compounds (VOCs, such as trichloroethylene) has been linked to an increased risk of Parkinson's in certain communities.
- Genetic factors: The Parkin gene and alpha-synuclein are implicated.
- Emerging research: Gut microbiome and inflammation are areas of ongoing study.
Secondary Parkinsonism
- Drug-induced causes: Dopamine blockers (antipsychotics, metoclopramide), dopamine depletors (methyldopa, reserpine), calcium channel blockers, antiepileptics, antidepressants, chemotherapy, and immunosuppressants.
- Medical causes: Normal pressure hydrocephalus (NPH), infarction, infections (e.g., neurosyphilis), trauma, and lesions/neoplasms affecting the substantia nigra.
Classification
- Idiopathic (unknown cause) vs. secondary Parkinson's
- Age of onset (young vs. old)
- Rate or progression (rapid vs. slow)
- Proposed subtypes (mild motor predominant, intermediate, diffuse malignant).
Epidemiology
- Incidence is 14-20 cases per 100,000 people (160 per 100,000 if aged 65 and above) in high-income countries.
- Prevalence is 300 cases per 100,000 population (may be as high as 572 per 100,000 for people aged 45 years and older).
- Race-related incidence is similar when comparing community populations, but significant early-onset rates exist when comparing early-onset residents to other residents.
- Lifetime risk at age 40 is about 2% for men and 1.3% for women, and these rates take competing risks like death from cardiovascular disease or cancer into account.
Hallmark Features
- Resting tremor
- Bradykinesia
- Rigidity
- Postural instability
- Festination Gait
- Shuffling Gait
Associated Characteristic Problems
- Motor symptoms (micrographia, masked face, decreased blink rate, shuffling gait, festination gait)
- Autonomic impairment (constipation, sweating, postural hypotension, dysphagia)
- Mental status (depression, cognitive impairment, dementia)
Canadian CPG for PD
- The guidelines for Parkinson's Disease begin with communication.
- Importance is placed on considering a holistic and palliative approach throughout the disease and diagnosis process.
- Guidelines address diagnosis, progression, treatment for motor symptoms in early and late PD, and surgical interventions.
Staging
- Hoehn and Yahr Scale is commonly used to stage Parkinson's disease based on symptom severity.
Goals of Therapy
- Relieve symptoms, maximize independence and function
- Prevent injury, prevent long-term drug complications
- Focus on quality of life
Questions - Answers
- Canadian CPG: The Canadian CPGs for Parkinson's disease begin with communication.
- Prognosis: The typical prognosis for midlife-onset Parkinson's disease is 1-2 years.
- Cause of death for most Parkinson's patients: None of those listed - Parkinson's does not directly kill.
Approach to Treatment
- Focuses on tremor and chronological age.
- Prioritizes patient function.
- Early-stage treatment options include levodopa and dopamine agonists.
Unified Parkinson's Disease Rating Scale (UPDRS)
- Rating scale used to track and monitor Parkinson's disease progression, including non-motor and motor aspects of daily living experiences, and motor complications.
Quality of Life (QOL) Measures - Parkinson's Impact Scale
- Measures self-perception, family relations, community relations, work, leisure, travel, safety, financial security, and sexuality.
AAN Guidelines
- Recommend starting treatment in early disease.
Dopamine Agonists
- Drugs used frequently to treat Parkinson's.
- Direct dopamine receptor stimulation. Minimizes the use of levodopa in early disease. Add-on option for levodopa in late stages.
DA (Older vs. Newer Agents)
- Older agents tend to be less receptor-specific, and lower cost.
- Newer agents are usually more receptor-specific, higher cost, lower adverse effects compared to older agents.
Levodopa
- Gold standard for PD treatment.
- Given in a combination with carbidopa or other entacapone to improve absorption and prevent early metabolism.
COMT Inhibitors (Entacapone, Tolcapone)
- Increase the duration of action of levodopa.
- Often used as an add-on to levodopa.
Adverse Effects of Medications in PD (ex: excessive daytime sleepiness)
- Excessive daytime sleepiness, confusion, nausea, orthostatic hypotension, hallucinations and dyskinesias.
Debates with Dopamine Agonists vs. Levodopa
- DA agonists tend to have a higher risk of side effects, requiring more frequent patient monitoring and sometimes result in a higher rate of treatment discontinuation.
- Levodopa is more effective for controlling many hallmarks of Parkinson's, but motor complications like dyskinesia tend to emerge in patients taking levodopa more frequently, and over a longer period compared to dopamine agonists.
Levodopa Pharmacodynamics
- The effects of levodopa tend to show a difference in intensity and duration over the course of the disease (during early, moderate, and advanced stages).
COMT Adverse Effects
- Confusion, nausea, and hallucinations, hepatotoxicity (tolcapone), Orthostasis.
Dietary Information and Interactions
- Protein with levodopa should be taken at a specific time of day or outside of medication administration.
- Certain medications in Parkinson's disease may interact with food items.
Surgical Interventions (DBS, etc.)
- Deep brain stimulation, thalamotomy, pallidotomy, fetal transplantation
- Overall, goal of these procedures is to improve the "on" time and quality of life for patients.
- Results tend to vary depending on patient case factors.
Monitoring for PD Treatments
- Tracking symptoms, improved or decreased function, LD dose, neurologic and cardiac toxicity.
Case Updates (Patient examples throughout the presentation)
- Case examples presented in the lecture/presentation allow for application of information to clinical cases.
Additional Considerations
- Understand the importance of considering the patient's values, preferences, and lifestyle regarding their treatment plan.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Related Documents
Description
Test your knowledge on the AAN guidelines for treating Parkinson's disease. This quiz covers medication choices, symptoms, and rehabilitation strategies highlighted in the guidelines. See how well you understand critical concepts such as clinical equipoise and the Unified Parkinson Disease Rating Scale.
